1-3 of 3
Michael Radmacher
Close
Sort by
Journal Articles

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

Klaus H. Metzeler, Manuela Hummel, Clara D. Bloomfield, Karsten Spiekermann, Jan Braess, Maria-Cristina Sauerland, Achim Heinecke, Michael Radmacher, Guido Marcucci, Susan P. Whitman, Kati Maharry, Peter Paschka, Richard A. Larson, Wolfgang E. Berdel, Thomas Büchner, Bernhard Wörmann, Ulrich Mansmann, Wolfgang Hiddemann, Stefan K. Bohlander, Christian Buske
Journal: Blood
Blood (2008) 112 (10): 4193–4201.
https://doi.org/10.1182/blood-2008-02-134411
Published: 2008
Includes: Supplemental data
Journal Articles

An 86-Probe Gene Expression Signature Can Predict Survival in AML with Normal Karyotype Independently of FLT3 ITD and NPM1 Mutation Status - A Collaborative Study from the AMLCG and CALGB Study Groups.

Klaus H. Metzeler, Manuela Hummel, Clara D. Bloomfield, Karsten Spiekermann, Maria C. Sauerland, Achim Heinecke, Michael Radmacher, Guido Marcucci, Susan P. Whitman, Kati Maharry, Peter Paschka, Richard A. Larson, Wolfgang E. Berdel, Thomas Büchner, Bernhard Wörmann, Ulrich Mansmann, Wolfgang Hiddemann, Stefan K. Bohlander, Christian Buske
Journal: Blood
Blood (2007) 110 (11): 596.
https://doi.org/10.1182/blood.V110.11.596.596
Published: 2007
Journal Articles

Co-Expression of BAALC with ERG, TCF4, and CD133 Indicates a Shared Pathway in Acute Myeloid and Lymphoblastic Leukemia.

Claudia D. Baldus, MD, Michael Radmacher, PhD, Guido Marcucci, MD, Dieter Hoelzer, MD, Eckhard Thiel, MD, Clara D. Bloomfield, MD, Wolf-Karsten Hofmann, MD
Journal: Blood
Blood (2005) 106 (11): 2755.
https://doi.org/10.1182/blood.V106.11.2755.2755
Published: 2005